Literature DB >> 19481339

Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen.

Takashige Masuo1, Shinichi Okamura, Yajing Zhang, Masatomo Mori.   

Abstract

The present study investigated the role of calcineurin (CaN) in the proliferation of human colorectal cancers. CaN activity and protein expression were increased in human colorectal cancers. Nuclear transcription factor NFAT, a physiological substrate for CaN, was activated in human colon cancer specimen as well as in the human colon cancer cell lines. CaN inhibitor cyclosporine A (CsA) reduced cell growth in these cell lines. CsA decreased the expressions of c-Myc and the proliferating cell nuclear antigen (PCNA) but also increased p21(WAF1/CIP1) expression. Our results suggest that CaN promotes colorectal cancer proliferation probably by regulating levels of c-Myc, p21(WAF1/CIP1), and PCNA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481339     DOI: 10.1016/j.canlet.2009.05.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Suppression of aberrant transient receptor potential cation channel, subfamily V, member 6 expression in hyperproliferative colonic crypts by dietary calcium.

Authors:  Sara Peleg; Joseph H Sellin; Yu Wang; Michael R Freeman; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-27       Impact factor: 4.052

Review 2.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

3.  Calcineurin promotes proliferation, migration, and invasion of small cell lung cancer.

Authors:  Yan Liu; Ye Zhang; Jie Min; Li-Li Liu; Ning-Qiang Ma; Ying-Ming Feng; Dong Liu; Ping-zhong Wang; De-Dong Huang; Yan Zhuang; He-Long Zhang
Journal:  Tumour Biol       Date:  2010-04-27

4.  Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway.

Authors:  Miriam B F Werneck; Eugênio Hottz; Patricia T Bozza; João P B Viola
Journal:  Cell Cycle       Date:  2012-09-19       Impact factor: 4.534

5.  The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis.

Authors:  Ning-Qiang Ma; Li-Li Liu; Jie Min; Jun-Wei Wang; Wei-Feng Jiang; Yan Liu; Yan-Guo Feng; Hai-Chuan Su; Ying-Ming Feng; He-Long Zhang
Journal:  Clin Exp Metastasis       Date:  2011-07-23       Impact factor: 5.150

Review 6.  Significant position of C-myc in colorectal cancer: a promising therapeutic target.

Authors:  Li Tan; Dong Peng; Yong Cheng
Journal:  Clin Transl Oncol       Date:  2022-08-16       Impact factor: 3.340

7.  Antiproliferative and apoptotic-inducing potential of ellagic acid against 1,2-dimethyl hydrazine-induced colon tumorigenesis in Wistar rats.

Authors:  Syed Umesalma; Ponnuraj Nagendraprabhu; Ganapasam Sudhandiran
Journal:  Mol Cell Biochem       Date:  2013-11-27       Impact factor: 3.396

8.  Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis.

Authors:  A Bigi; E Beltrami; M Trinei; M Stendardo; P G Pelicci; M Giorgio
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

9.  Epithelial calcineurin controls microbiota-dependent intestinal tumor development.

Authors:  Kenneth Peuker; Stefanie Muff; Jun Wang; Sven Künzel; Esther Bosse; Yvonne Zeissig; Giuseppina Luzzi; Marijana Basic; Anne Strigli; Andrea Ulbricht; Arthur Kaser; Alexander Arlt; Triantafyllos Chavakis; Gijs R van den Brink; Clemens Schafmayer; Jan-Hendrik Egberts; Thomas Becker; Marco E Bianchi; André Bleich; Christoph Röcken; Jochen Hampe; Stefan Schreiber; John F Baines; Richard S Blumberg; Sebastian Zeissig
Journal:  Nat Med       Date:  2016-04-04       Impact factor: 53.440

10.  Examining the relationship between diet-induced acidosis and cancer.

Authors:  Ian Forrest Robey
Journal:  Nutr Metab (Lond)       Date:  2012-08-01       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.